Alcidion Selected as Preferred EPR Supplier
| Stock | Alcidion Group Ltd (ALC.ASX) |
|---|---|
| Release Time | 8 Jan 2026, 8:24 a.m. |
| Price Sensitive | Yes |
Alcidion Selected as Preferred EPR Supplier
- University Hospitals Sussex NHS Foundation Trust (UHSx) has selected Alcidion as the preferred supplier for its new Electronic Patient Record (EPR) system
- Total Contract Value (TCV) is under negotiation, anticipated to be in excess of A$35M over a minimum 7-year period
- Alcidion will deploy its flagship Miya Precision platform, including Miya Observations and Assessments (Patientrack)
Alcidion Group Limited (ASX: ALC) has been selected as the preferred EPR supplier by University Hospitals Sussex NHS Foundation Trust (UHSx) for its new Electronic Patient Record (EPR) system. UHSx is located in the south of the UK and forms part of the Sussex Integrated Care System (ICS), providing hospital and community health care for approximately a million people in Sussex. It is one of the largest acute trusts in the UK, with seven hospitals hosting more than 1.5 million outpatient appointments, A&E visits and surgery cases annually, employing nearly 20,000 staff. Alcidion will deploy its flagship Miya Precision platform, including Miya Observations and Assessments (Patientrack), which is already live at the Trust. The EPR solution will provide clinicians real-time access to patient records while streamlining patient flow and improving clinical decision-making processes. Following a competitive tender process, Alcidion and UHSx will now finalise the contract prior to commencing deployment of Miya Precision, which is expected to begin in Q4 FY26. The total contract value (TCV) is under negotiation and is anticipated to be in excess of A$35M, depending on the number of modules included, over a minimum 7-year period.
The total contract value (TCV) is under negotiation and is anticipated to be in excess of A$35M, depending on the number of modules included, over a minimum 7-year period.